Evaluation of Hepatic Enzymes in major β-thalassemic Patients using Deferasirox

Abstract β-thalassemia major is a genetic disease that causes sever defect in normal hemoglobin synthesis. The patients with β-thalassemia major need periodic blood transfusions that can result in accumulation of body iron, so treatment with iron chelating agent is required. Complications of this...

Full description

Bibliographic Details
Published in:Iraqi Journal of Pharmaceutical Sciences
Main Authors: Ahmed Yahya Dallal Bashi, Fatimah Haitham Fathi
Format: Article
Language:English
Published: College of Pharmacy University of Baghdad 2022-12-01
Subjects:
Online Access:https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/1605